Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shreya Armstrong"'
Publikováno v:
Journal of Medical Imaging and Radiation Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d05f469759ea6ce39402114be305cf3d
https://doi.org/10.1111/1754-9485.13542
https://doi.org/10.1111/1754-9485.13542
Publikováno v:
Journal of Medical Imaging and Radiation Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5f305fe8cfedaec7c3c6df4a40d1286
https://doi.org/10.1111/1754-9485.13534
https://doi.org/10.1111/1754-9485.13534
Autor:
Robert Hughes, Shreya Armstrong, Roberto Alonzi, Stephanie Brown, Peter Ostler, May Stancliffe, Peter Hoskin
Publikováno v:
Radiotherapy and Oncology. 159:67-74
Aim The dominant intraprostatic lesion (DIL) is the commonest site of relapse after single dose high-dose-rate brachytherapy (HDR-BT) for localised prostate cancer. This study investigated toxicity and clinical outcomes of focal dose escalation to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab20d29d34d2c74d1b6852d971a1d0a
https://doi.org/10.1016/j.radonc.2021.03.018
https://doi.org/10.1016/j.radonc.2021.03.018
Autor:
Peter Ostler, Peter Hoskin, Gerry Lowe, Hannah Tharmalingam, Robert Hughes, Roberto Alonzi, Y. Tsang, Shreya Armstrong
Publikováno v:
Radiotherapy and Oncology. 157:93-98
Purpose/objective Long-term follow up of single dose high-dose rate brachytherapy (HDR BT) for localised prostate cancer has revealed higher than expected rates of biochemical and local failure. This study aimed (i) to investigate the pattern of rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2986e9412ef9c453ce0558795528a7
https://doi.org/10.1016/j.radonc.2021.01.006
https://doi.org/10.1016/j.radonc.2021.01.006
Autor:
Peter Hoskin, Peter Ostler, Katherine Belessiotis-Richards, Roberto Alonzi, Robert Hughes, Y. Tsang, Shreya Armstrong, Hannah Tharmalingam
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 158
To compare the biochemical control rates (BCRs), late gastrointestinal (GI) and genitourinary (GU) toxicities in patients with low- and intermediate risk prostate cancer (PCa) treated with high-dose-rate brachytherapy (HDR BT) of 19 Gy/1 fraction, 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a30bd73fcaa12ead1785396c4b03c22
https://pubmed.ncbi.nlm.nih.gov/34942282
https://pubmed.ncbi.nlm.nih.gov/34942282
Autor:
Y. Tsang, K. Belessiotis-Richards, Peter Ostler, Hannah Tharmalingam, Shreya Armstrong, Robert Hughes, Roberto Alonzi, Peter Hoskin
Publikováno v:
Radiotherapy and Oncology. 158:S27-S28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ddbac18b117641f79bfe5dd5c0763b5
https://doi.org/10.1016/s0167-8140(21)06282-4
https://doi.org/10.1016/s0167-8140(21)06282-4
Publikováno v:
Australasian Journal of Dermatology. 58:150-151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d79b2127333d2922a053317a3f4107
https://doi.org/10.1111/ajd.12513
https://doi.org/10.1111/ajd.12513